Allergic manifestations in very low-birthweight infants: a 6-year follow-up

M Agosti1, C Vegni, S Gangi

  • 1Istituto Pediatria-Neonatologia, University of Milan, Italy. massimo.agosti@ospedale.varese.it

Insights

Very low-birthweight infants (VLBWIs) show lower overall allergy incidence compared to full-term infants by age two. However, VLBWIs have a higher prevalence of asthma (AS) but less atopic dermatitis (AD).

Area of Science:

  • Pediatrics
  • Allergology
  • Neonatology

Background:

  • Allergic diseases are a significant health concern in childhood.
  • Understanding the long-term allergic outcomes for very low-birthweight infants (VLBWIs) is crucial for early intervention.

Purpose of the Study:

  • To compare the incidence of allergic manifestations in VLBWIs with full-term infants up to six years of age.
  • To identify specific allergic conditions prevalent in VLBWIs and their associated risk factors.

Main Methods:

  • Prospective follow-up of 83 VLBWIs from birth to 6 years and 98 full-term infants from birth to 2 years.
  • Clinical examinations by pediatricians to diagnose atopic dermatitis (AD), gastrointestinal disturbances (GD), and asthma (AS).
  • Analysis of allergy incidence across different VLBWI subgroups based on birth weight, gestational age, and SGA status.

Main Results:

  • Overall allergic manifestations were significantly lower in VLBWIs (31.3%) compared to full-term infants (52%) by 24 months.
  • Atopic dermatitis (AD) was more common in full-term infants (33.7%) than VLBWIs (7.2%).
  • Asthma (AS) incidence was significantly higher in VLBWIs (16.8%) than full-term infants (10.2%).
  • Gastrointestinal disturbances (GD) showed similar incidence in both groups.
  • Specific risk factors within VLBWIs included birth weight, gestational age, and SGA status for different allergic conditions.

Conclusions:

  • VLBWIs exhibit a distinct allergic manifestation profile compared to full-term infants, with a lower overall incidence but a higher risk of asthma.
  • Early identification of risk factors within VLBWI subgroups can guide targeted monitoring and management strategies.
  • Family history of allergy is a significant predictor for allergy development in infants.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Allergic Reactions02:06

Allergic Reactions

Overview
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...